“Key Supplier Risk
Biome's key supplier risk stems from its reliance on only two suppliers in Europe for its core probiotic products.
Sourcing products from a limited number of suppliers exposes Biome to potential disruptions in the supply chain.
Biome's ability to meet customer demand and maintain sales revenue could be severely impacted if these suppliers cannot fulfil their obligations due to production issues, regulatory challenges, or unforeseen circumstances.
Biome's owned formulations (Biome Daily, Biome Daily Kids, Biome IBS, Biome Advanced & Biome Prenatal) account for just over 70% of probiotic sales.
Non-owned formulations are under 5-year exclusivity agreements for the company's territories.
Why wrong?
Thanks
- Forums
- ASX - By Stock
- New Canary Report - Price update to $1.10
“Key Supplier Risk Biome's key supplier risk stems from its...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
65.0¢ |
Change
-0.020(2.99%) |
Mkt cap ! $142.4M |
Open | High | Low | Value | Volume |
68.0¢ | 68.0¢ | 64.0¢ | $118.4K | 180.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 81106 | 65.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
65.5¢ | 2801 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 81106 | 0.650 |
1 | 2688 | 0.645 |
8 | 35654 | 0.640 |
4 | 34188 | 0.635 |
1 | 1587 | 0.630 |
Price($) | Vol. | No. |
---|---|---|
0.655 | 2801 | 1 |
0.660 | 12688 | 2 |
0.665 | 2688 | 1 |
0.670 | 22688 | 2 |
0.675 | 10000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online